Project
avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for SP3
Z-value: 12.31
Motif logo
Transcription factors associated with SP3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SP3
|
ENSG00000172845.18 | SP3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SP3 | hg38_v1_chr2_-_173964180_173964240, hg38_v1_chr2_-_173964069_173964157 | 0.66 | 6.7e-29 | Click! |
Activity profile of SP3 motif
Sorted Z-values of SP3 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of SP3
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 48.0 | 239.8 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 42.8 | 171.1 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 40.4 | 161.6 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 39.9 | 119.7 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 39.0 | 39.0 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 37.3 | 186.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 35.9 | 143.5 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 35.6 | 142.3 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 34.2 | 136.9 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 32.5 | 65.1 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 31.7 | 348.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 31.1 | 93.3 | GO:0051793 | medium-chain fatty acid catabolic process(GO:0051793) |
| 30.2 | 30.2 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 30.1 | 90.2 | GO:1902822 | regulation of late endosome to lysosome transport(GO:1902822) |
| 29.9 | 179.5 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 29.9 | 119.4 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 29.2 | 87.7 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 29.2 | 116.7 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 28.7 | 28.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 28.4 | 85.3 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 27.5 | 137.3 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 27.2 | 81.7 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
| 27.1 | 27.1 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 26.3 | 52.6 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 26.0 | 182.3 | GO:0006231 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 25.9 | 77.6 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 25.8 | 77.4 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 25.1 | 100.3 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 24.9 | 249.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 24.9 | 124.4 | GO:0015862 | uridine transport(GO:0015862) |
| 24.7 | 49.4 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 24.7 | 98.7 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 24.2 | 72.7 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 23.7 | 118.3 | GO:0035900 | response to isolation stress(GO:0035900) |
| 23.3 | 116.6 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 23.3 | 116.6 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 23.3 | 116.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
| 22.8 | 318.5 | GO:1904869 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 22.5 | 90.2 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 22.3 | 156.1 | GO:0032218 | riboflavin transport(GO:0032218) |
| 22.2 | 88.8 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 22.1 | 88.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 22.0 | 88.1 | GO:0007144 | female meiosis I(GO:0007144) |
| 22.0 | 131.7 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 21.8 | 87.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 21.5 | 322.9 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 21.5 | 64.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 21.4 | 150.1 | GO:0030421 | defecation(GO:0030421) |
| 21.3 | 63.9 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 21.2 | 42.3 | GO:0008615 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 biosynthetic process(GO:0042819) |
| 20.9 | 83.5 | GO:0090095 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 20.9 | 62.6 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 20.7 | 62.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 20.5 | 81.8 | GO:2000426 | plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 20.3 | 142.0 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
| 20.1 | 60.4 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 20.1 | 100.6 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 20.1 | 80.4 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 20.0 | 100.1 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 20.0 | 59.9 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 19.6 | 58.7 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 19.5 | 312.5 | GO:0043248 | proteasome assembly(GO:0043248) |
| 19.3 | 425.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 19.2 | 249.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 19.0 | 57.0 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 18.9 | 94.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 18.6 | 93.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 18.5 | 74.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 18.4 | 202.4 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 18.4 | 146.8 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
| 18.3 | 54.9 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 18.2 | 36.4 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
| 18.1 | 108.9 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 18.1 | 36.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 18.1 | 162.8 | GO:0006265 | DNA topological change(GO:0006265) |
| 18.0 | 90.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 17.9 | 53.6 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 17.6 | 35.2 | GO:0070476 | RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
| 17.6 | 211.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 17.5 | 70.0 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 17.4 | 52.3 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 17.3 | 121.3 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 17.3 | 69.3 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 17.2 | 172.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 17.2 | 86.0 | GO:0060613 | fat pad development(GO:0060613) |
| 17.1 | 68.4 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
| 17.1 | 51.3 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 17.0 | 51.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 17.0 | 17.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 16.8 | 101.0 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 16.8 | 67.2 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 16.6 | 49.9 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 16.3 | 98.0 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
| 16.1 | 96.8 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 16.1 | 273.8 | GO:0042761 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
| 16.0 | 64.0 | GO:0043335 | protein unfolding(GO:0043335) |
| 15.8 | 63.4 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 15.8 | 63.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 15.8 | 63.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 15.8 | 94.7 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 15.8 | 47.3 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 15.7 | 62.7 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 15.6 | 46.9 | GO:1902905 | positive regulation of fibril organization(GO:1902905) |
| 15.5 | 46.6 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 15.5 | 185.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 15.5 | 108.2 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 15.4 | 123.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 15.4 | 15.4 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
| 15.4 | 15.4 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 15.4 | 15.4 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
| 15.2 | 45.7 | GO:1901389 | regulation of transforming growth factor beta activation(GO:1901388) negative regulation of transforming growth factor beta activation(GO:1901389) |
| 15.2 | 380.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 15.2 | 90.9 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 15.0 | 105.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 14.9 | 119.5 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 14.9 | 89.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 14.8 | 44.3 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 14.7 | 44.2 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 14.7 | 323.2 | GO:0051639 | actin filament network formation(GO:0051639) |
| 14.6 | 58.4 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 14.6 | 43.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 14.5 | 43.6 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 14.5 | 116.1 | GO:0055129 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
| 14.5 | 43.5 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 14.4 | 14.4 | GO:0015809 | arginine transport(GO:0015809) |
| 14.4 | 43.2 | GO:1902594 | viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
| 14.4 | 57.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 14.3 | 200.8 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 14.2 | 14.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 14.2 | 42.5 | GO:0060957 | endocardial cell fate commitment(GO:0060957) endocardial cushion cell fate commitment(GO:0061445) |
| 14.1 | 42.4 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
| 14.1 | 197.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 14.0 | 196.6 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 13.9 | 41.8 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 13.9 | 41.6 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 13.8 | 41.4 | GO:1904387 | response to human chorionic gonadotropin(GO:0044752) cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 13.8 | 27.5 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 13.7 | 109.9 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 13.7 | 68.7 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 13.7 | 95.8 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 13.6 | 218.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 13.5 | 108.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 13.5 | 13.5 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 13.4 | 120.5 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 13.4 | 13.4 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 13.3 | 40.0 | GO:0061163 | endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 13.3 | 40.0 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 13.3 | 159.5 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 13.3 | 145.9 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 13.2 | 52.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 13.0 | 181.9 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 13.0 | 51.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 13.0 | 51.8 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 12.9 | 51.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 12.9 | 51.7 | GO:0018201 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 12.9 | 51.6 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 12.7 | 51.0 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 12.7 | 38.2 | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 12.7 | 12.7 | GO:0048254 | snoRNA localization(GO:0048254) |
| 12.7 | 50.9 | GO:0030047 | actin modification(GO:0030047) |
| 12.7 | 63.4 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 12.7 | 12.7 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
| 12.7 | 38.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 12.7 | 50.6 | GO:0044206 | pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) |
| 12.6 | 50.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 12.6 | 63.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 12.6 | 37.7 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 12.6 | 75.3 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 12.6 | 50.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 12.5 | 25.0 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 12.5 | 62.3 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 12.4 | 87.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 12.4 | 384.7 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 12.4 | 74.4 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 12.3 | 12.3 | GO:0010225 | response to UV-C(GO:0010225) |
| 12.3 | 49.1 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 12.2 | 36.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 12.1 | 48.6 | GO:1903786 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 12.0 | 84.1 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
| 12.0 | 108.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 12.0 | 48.0 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 12.0 | 48.0 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 12.0 | 71.8 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 11.9 | 47.7 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 11.8 | 58.9 | GO:1904753 | negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
| 11.8 | 11.8 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 11.7 | 46.7 | GO:0032600 | B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 11.6 | 46.5 | GO:1903332 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) regulation of protein folding(GO:1903332) negative regulation of protein folding(GO:1903333) |
| 11.6 | 23.2 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 11.6 | 23.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 11.6 | 115.9 | GO:0009414 | response to water deprivation(GO:0009414) |
| 11.5 | 46.0 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 11.5 | 45.9 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 11.4 | 68.5 | GO:0015853 | adenine transport(GO:0015853) |
| 11.4 | 867.6 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 11.3 | 45.3 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 11.2 | 56.1 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 11.1 | 78.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 11.1 | 178.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 11.1 | 111.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 11.0 | 220.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 11.0 | 44.1 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 11.0 | 110.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 11.0 | 22.0 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 10.9 | 21.9 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 10.9 | 130.5 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 10.9 | 10.9 | GO:1901355 | response to rapamycin(GO:1901355) |
| 10.8 | 32.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 10.8 | 54.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 10.8 | 54.0 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 10.8 | 10.8 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 10.7 | 42.8 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 10.7 | 42.7 | GO:0006404 | RNA import into nucleus(GO:0006404) |
| 10.7 | 117.2 | GO:0042262 | DNA protection(GO:0042262) |
| 10.6 | 10.6 | GO:0009838 | abscission(GO:0009838) |
| 10.6 | 31.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 10.6 | 137.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 10.5 | 52.5 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
| 10.5 | 62.9 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 10.4 | 20.9 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 10.4 | 31.2 | GO:0014810 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014810) |
| 10.4 | 41.5 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 10.3 | 20.7 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 10.3 | 10.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 10.3 | 10.3 | GO:0048378 | lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 10.3 | 41.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 10.3 | 41.0 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 10.2 | 20.4 | GO:0072019 | proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
| 10.2 | 20.4 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 10.2 | 30.6 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 10.2 | 10.2 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 10.2 | 91.8 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 10.2 | 162.6 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 10.2 | 60.9 | GO:0007296 | vitellogenesis(GO:0007296) |
| 10.1 | 1002.6 | GO:0051439 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 10.1 | 20.2 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 10.1 | 120.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 10.0 | 59.8 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 10.0 | 10.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 9.9 | 89.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 9.9 | 9.9 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
| 9.8 | 19.7 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 9.8 | 19.5 | GO:0015866 | ADP transport(GO:0015866) |
| 9.8 | 117.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 9.8 | 87.9 | GO:1902661 | positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 9.7 | 58.5 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 9.7 | 48.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 9.7 | 19.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 9.6 | 28.9 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 9.6 | 28.7 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 9.5 | 38.0 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 9.5 | 75.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 9.5 | 66.3 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 9.5 | 28.4 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
| 9.5 | 18.9 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 9.4 | 18.9 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 9.4 | 56.6 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
| 9.4 | 18.9 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
| 9.4 | 141.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 9.4 | 18.8 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) |
| 9.4 | 28.1 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 9.3 | 46.7 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 9.3 | 65.4 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 9.3 | 9.3 | GO:1903911 | positive regulation of receptor clustering(GO:1903911) |
| 9.3 | 55.9 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 9.2 | 652.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 9.2 | 45.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 9.2 | 404.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 9.2 | 27.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 9.1 | 9.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 9.1 | 72.8 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 9.1 | 45.3 | GO:1900369 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
| 9.0 | 54.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 9.0 | 54.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 9.0 | 53.9 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 9.0 | 62.7 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 8.9 | 26.6 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 8.9 | 44.4 | GO:0003164 | His-Purkinje system development(GO:0003164) |
| 8.9 | 106.4 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 8.8 | 159.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 8.8 | 26.4 | GO:0002188 | translation reinitiation(GO:0002188) |
| 8.8 | 246.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 8.8 | 8.8 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 8.8 | 149.1 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 8.7 | 34.9 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 8.7 | 26.2 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
| 8.7 | 8.7 | GO:0009209 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
| 8.7 | 26.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 8.7 | 121.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 8.6 | 77.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 8.6 | 17.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 8.5 | 25.6 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 8.5 | 25.6 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 8.5 | 127.7 | GO:0070986 | left/right axis specification(GO:0070986) |
| 8.5 | 25.5 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 8.5 | 17.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 8.4 | 33.8 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 8.4 | 67.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 8.4 | 142.8 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 8.4 | 67.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 8.3 | 75.1 | GO:2000580 | regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 8.3 | 75.0 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 8.3 | 8.3 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 8.3 | 190.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 8.3 | 90.9 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 8.2 | 32.8 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
| 8.2 | 8.2 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 8.2 | 24.6 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
| 8.2 | 40.9 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
| 8.2 | 57.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 8.2 | 73.5 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 8.2 | 16.3 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
| 8.1 | 8.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 8.1 | 32.5 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 8.1 | 113.6 | GO:0045116 | protein neddylation(GO:0045116) |
| 8.1 | 24.2 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 8.1 | 40.3 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 8.1 | 48.3 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 8.0 | 64.3 | GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) |
| 8.0 | 32.1 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 8.0 | 55.9 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 8.0 | 55.9 | GO:0030473 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 8.0 | 31.9 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 7.9 | 39.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 7.9 | 47.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 7.8 | 15.5 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
| 7.8 | 7.8 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 7.8 | 54.3 | GO:0015846 | polyamine transport(GO:0015846) |
| 7.7 | 23.2 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 7.7 | 177.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 7.7 | 84.7 | GO:0060056 | mammary gland involution(GO:0060056) |
| 7.7 | 30.7 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 7.7 | 30.7 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 7.7 | 91.9 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
| 7.6 | 99.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 7.6 | 22.8 | GO:0031550 | positive regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031550) |
| 7.6 | 7.6 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 7.6 | 30.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 7.6 | 37.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 7.6 | 22.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 7.5 | 22.6 | GO:0051182 | coenzyme transport(GO:0051182) |
| 7.5 | 90.6 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 7.5 | 15.1 | GO:0046543 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
| 7.5 | 30.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 7.5 | 15.1 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 7.5 | 22.6 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 7.5 | 37.4 | GO:0070269 | pyroptosis(GO:0070269) |
| 7.4 | 37.1 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
| 7.4 | 29.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 7.4 | 7.4 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 7.4 | 22.1 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
| 7.3 | 7.3 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 7.3 | 21.9 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 7.2 | 21.7 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 7.2 | 86.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 7.2 | 21.6 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 7.2 | 143.7 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 7.2 | 71.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 7.2 | 50.1 | GO:2000230 | response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 7.1 | 21.4 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 7.1 | 21.3 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 7.1 | 64.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 7.1 | 35.5 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
| 7.1 | 71.0 | GO:0046689 | response to mercury ion(GO:0046689) |
| 7.1 | 21.2 | GO:0042946 | glucoside transport(GO:0042946) |
| 7.1 | 14.1 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 7.1 | 14.1 | GO:1902415 | regulation of mRNA binding(GO:1902415) |
| 7.0 | 84.6 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
| 7.0 | 42.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 7.0 | 28.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 6.9 | 6.9 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 6.9 | 20.8 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 6.9 | 20.7 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 6.9 | 75.9 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 6.9 | 89.4 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 6.9 | 48.1 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 6.9 | 185.5 | GO:0034080 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 6.9 | 20.6 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 6.9 | 27.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 6.8 | 6.8 | GO:0060066 | oviduct development(GO:0060066) |
| 6.8 | 68.3 | GO:0060717 | chorion development(GO:0060717) |
| 6.8 | 109.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 6.8 | 34.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 6.8 | 6.8 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 6.8 | 6.8 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 6.8 | 20.3 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 6.7 | 53.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 6.7 | 20.2 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 6.7 | 33.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 6.7 | 33.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 6.7 | 26.9 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 6.6 | 19.9 | GO:2000619 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 6.6 | 13.3 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 6.6 | 33.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 6.6 | 19.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 6.6 | 33.0 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
| 6.6 | 39.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 6.6 | 13.1 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 6.5 | 19.6 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 6.5 | 124.1 | GO:0006101 | citrate metabolic process(GO:0006101) |
| 6.5 | 97.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 6.5 | 84.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 6.5 | 25.8 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 6.5 | 25.8 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 6.4 | 6.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 6.4 | 38.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 6.4 | 473.9 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 6.4 | 38.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 6.4 | 19.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 6.4 | 19.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 6.3 | 63.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 6.3 | 12.7 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 6.3 | 19.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 6.3 | 25.3 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 6.3 | 25.2 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 6.3 | 12.5 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 6.3 | 43.8 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 6.3 | 81.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 6.2 | 55.9 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
| 6.2 | 24.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 6.2 | 12.4 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
| 6.2 | 12.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 6.2 | 18.5 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 6.1 | 110.6 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 6.1 | 159.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 6.1 | 134.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 6.1 | 42.8 | GO:0030091 | protein repair(GO:0030091) |
| 6.1 | 55.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 6.1 | 30.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 6.1 | 48.8 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 6.1 | 12.2 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 6.1 | 231.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 6.1 | 97.3 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
| 6.1 | 48.5 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
| 6.1 | 12.1 | GO:0046031 | ADP metabolic process(GO:0046031) |
| 6.1 | 12.1 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 6.1 | 54.5 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 6.1 | 30.3 | GO:0006574 | valine catabolic process(GO:0006574) |
| 6.0 | 42.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 6.0 | 24.1 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 6.0 | 54.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 6.0 | 215.9 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 6.0 | 23.9 | GO:0031179 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 6.0 | 17.9 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 6.0 | 6.0 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 6.0 | 59.6 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 6.0 | 23.8 | GO:0000012 | single strand break repair(GO:0000012) |
| 5.9 | 23.7 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 5.9 | 29.6 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 5.9 | 17.7 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 5.9 | 41.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 5.9 | 5.9 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 5.9 | 29.4 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 5.9 | 11.7 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 5.8 | 163.5 | GO:0006465 | signal peptide processing(GO:0006465) |
| 5.8 | 17.5 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
| 5.8 | 40.8 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 5.8 | 58.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 5.8 | 5.8 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 5.8 | 75.4 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 5.8 | 11.5 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
| 5.7 | 51.7 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 5.7 | 5.7 | GO:0021539 | subthalamus development(GO:0021539) |
| 5.7 | 102.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 5.7 | 17.1 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 5.7 | 34.2 | GO:0001765 | membrane raft assembly(GO:0001765) |
| 5.7 | 170.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 5.6 | 62.0 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 5.6 | 5.6 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 5.6 | 11.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 5.6 | 78.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 5.6 | 11.2 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
| 5.6 | 61.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 5.6 | 50.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 5.5 | 11.1 | GO:0048102 | autophagic cell death(GO:0048102) |
| 5.5 | 16.5 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 5.5 | 5.5 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
| 5.5 | 44.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 5.5 | 22.0 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 5.5 | 11.0 | GO:0009180 | ADP biosynthetic process(GO:0006172) nucleoside diphosphate biosynthetic process(GO:0009133) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 5.5 | 5.5 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
| 5.5 | 365.8 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
| 5.4 | 21.8 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
| 5.4 | 10.8 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 5.4 | 16.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 5.4 | 16.1 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 5.4 | 160.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 5.3 | 32.1 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 5.3 | 37.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 5.3 | 32.0 | GO:0006415 | translational termination(GO:0006415) |
| 5.3 | 79.9 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 5.3 | 5.3 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
| 5.3 | 89.7 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 5.3 | 15.8 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 5.2 | 41.9 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 5.2 | 36.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 5.2 | 10.4 | GO:0000967 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 5.2 | 31.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 5.2 | 10.3 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
| 5.2 | 118.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 5.1 | 313.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 5.1 | 10.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 5.1 | 45.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 5.1 | 30.5 | GO:0031337 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
| 5.1 | 60.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 5.1 | 15.2 | GO:0070203 | regulation of establishment of protein localization to telomere(GO:0070203) |
| 5.1 | 50.5 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 5.0 | 15.1 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 5.0 | 50.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 5.0 | 5.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 4.9 | 49.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 4.9 | 14.7 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 4.9 | 14.6 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 4.9 | 87.6 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 4.9 | 14.6 | GO:0010768 | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010768) transmission of virus(GO:0019089) dissemination or transmission of symbiont from host(GO:0044007) dissemination or transmission of organism from other organism involved in symbiotic interaction(GO:0051821) |
| 4.8 | 43.3 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
| 4.8 | 14.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 4.8 | 19.2 | GO:0008215 | spermine metabolic process(GO:0008215) |
| 4.8 | 33.5 | GO:0051096 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 4.7 | 33.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 4.7 | 14.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 4.7 | 9.5 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 4.7 | 18.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 4.7 | 14.1 | GO:0090176 | microtubule cytoskeleton organization involved in establishment of planar polarity(GO:0090176) |
| 4.7 | 9.3 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 4.7 | 18.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 4.6 | 18.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 4.6 | 18.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 4.6 | 23.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 4.6 | 18.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 4.6 | 60.0 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 4.6 | 9.2 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 4.6 | 9.2 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 4.6 | 4.6 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 4.6 | 4.6 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 4.6 | 36.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 4.5 | 40.9 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 4.5 | 72.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 4.5 | 45.2 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 4.5 | 22.4 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 4.5 | 8.9 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 4.4 | 26.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 4.4 | 17.7 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 4.4 | 22.1 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 4.4 | 4.4 | GO:0043144 | snoRNA processing(GO:0043144) |
| 4.4 | 439.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 4.4 | 17.5 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 4.4 | 140.3 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 4.4 | 17.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 4.4 | 21.8 | GO:0051451 | myoblast migration(GO:0051451) |
| 4.3 | 8.7 | GO:0048539 | bone marrow development(GO:0048539) |
| 4.3 | 125.5 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 4.3 | 47.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 4.3 | 8.6 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 4.3 | 55.8 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 4.3 | 8.6 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 4.3 | 17.1 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 4.3 | 42.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 4.3 | 68.5 | GO:0033260 | nuclear DNA replication(GO:0033260) |
| 4.3 | 8.5 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 4.3 | 89.5 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 4.3 | 76.7 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 4.2 | 25.4 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 4.2 | 8.4 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 4.2 | 25.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 4.2 | 50.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 4.2 | 4.2 | GO:0072174 | metanephric tubule formation(GO:0072174) |
| 4.2 | 37.7 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 4.2 | 29.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 4.2 | 33.4 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 4.1 | 116.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 4.1 | 8.3 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
| 4.1 | 37.1 | GO:0007379 | segment specification(GO:0007379) |
| 4.1 | 8.2 | GO:0001999 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 4.1 | 65.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 4.1 | 12.3 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 4.1 | 57.3 | GO:0032392 | DNA geometric change(GO:0032392) |
| 4.1 | 73.5 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 4.1 | 8.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 4.1 | 12.2 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 4.1 | 125.7 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 4.1 | 16.2 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 4.0 | 24.1 | GO:0060356 | leucine import(GO:0060356) |
| 4.0 | 24.1 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 4.0 | 20.1 | GO:0015677 | copper ion import(GO:0015677) |
| 4.0 | 24.0 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 4.0 | 4.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 4.0 | 15.9 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 4.0 | 11.9 | GO:2000706 | amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 3.9 | 3.9 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 3.9 | 63.1 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 3.9 | 11.8 | GO:0001832 | blastocyst growth(GO:0001832) |
| 3.9 | 15.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 3.9 | 23.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 3.9 | 7.8 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 3.9 | 62.4 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
| 3.8 | 23.1 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 3.8 | 3.8 | GO:0071336 | submandibular salivary gland formation(GO:0060661) white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 3.8 | 19.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 3.8 | 11.4 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 3.8 | 7.6 | GO:0040031 | snRNA modification(GO:0040031) |
| 3.8 | 151.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 3.8 | 138.9 | GO:0007031 | peroxisome organization(GO:0007031) |
| 3.7 | 37.5 | GO:0006907 | pinocytosis(GO:0006907) |
| 3.7 | 11.2 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 3.7 | 14.9 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 3.7 | 29.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 3.7 | 11.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 3.7 | 11.1 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 3.7 | 11.1 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 3.7 | 7.3 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 3.7 | 22.0 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
| 3.7 | 58.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 3.7 | 84.0 | GO:0035329 | hippo signaling(GO:0035329) |
| 3.7 | 11.0 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 3.7 | 11.0 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 3.6 | 36.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 3.6 | 105.1 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 3.6 | 36.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 3.6 | 28.8 | GO:0061316 | canonical Wnt signaling pathway involved in heart development(GO:0061316) |
| 3.6 | 7.2 | GO:0010044 | response to aluminum ion(GO:0010044) |
| 3.6 | 3.6 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 3.6 | 32.2 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 3.6 | 35.6 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
| 3.6 | 53.3 | GO:0090383 | phagosome acidification(GO:0090383) |
| 3.5 | 10.6 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 3.5 | 7.1 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 3.5 | 161.4 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 3.5 | 10.5 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
| 3.5 | 34.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 3.5 | 10.4 | GO:2000489 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
| 3.5 | 10.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 3.5 | 7.0 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 3.5 | 146.1 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
| 3.5 | 48.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 3.5 | 10.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 3.5 | 13.8 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 3.5 | 13.8 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
| 3.4 | 3.4 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) |
| 3.4 | 13.8 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 3.4 | 20.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 3.4 | 3.4 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 3.4 | 44.2 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 3.4 | 20.3 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 3.4 | 33.9 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 3.4 | 23.7 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 3.4 | 16.9 | GO:0002934 | desmosome organization(GO:0002934) |
| 3.4 | 16.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 3.4 | 16.8 | GO:0080009 | mRNA methylation(GO:0080009) |
| 3.4 | 13.5 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 3.4 | 16.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 3.4 | 37.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 3.4 | 6.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 3.4 | 10.1 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 3.3 | 73.6 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 3.3 | 63.4 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 3.3 | 6.7 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 3.3 | 53.1 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
| 3.3 | 59.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 3.3 | 13.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 3.3 | 13.1 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
| 3.3 | 26.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 3.3 | 58.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 3.3 | 9.8 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 3.3 | 19.6 | GO:0042182 | ketone catabolic process(GO:0042182) |
| 3.3 | 3.3 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 3.3 | 9.8 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
| 3.3 | 22.8 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 3.2 | 3.2 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 3.2 | 29.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 3.2 | 6.4 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 3.2 | 9.6 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 3.2 | 22.5 | GO:0042407 | cristae formation(GO:0042407) |
| 3.2 | 25.6 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 3.2 | 12.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 3.2 | 3.2 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 3.2 | 38.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
| 3.2 | 9.5 | GO:0090188 | signal transduction by trans-phosphorylation(GO:0023016) negative regulation of pancreatic juice secretion(GO:0090188) |
| 3.1 | 9.4 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 3.1 | 12.5 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 3.1 | 34.3 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 3.1 | 6.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 3.1 | 34.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 3.1 | 3.1 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 3.1 | 12.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 3.1 | 24.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 3.1 | 30.8 | GO:0000022 | mitotic spindle elongation(GO:0000022) |
| 3.1 | 36.9 | GO:0046040 | IMP metabolic process(GO:0046040) |
| 3.1 | 18.4 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 3.1 | 15.3 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 3.1 | 12.2 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 3.0 | 12.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 3.0 | 182.4 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 3.0 | 9.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 3.0 | 12.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 3.0 | 21.2 | GO:0042255 | ribosome assembly(GO:0042255) |
| 3.0 | 63.3 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
| 3.0 | 12.1 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
| 3.0 | 9.0 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 3.0 | 30.1 | GO:0033622 | integrin activation(GO:0033622) |
| 3.0 | 24.0 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 3.0 | 11.9 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
| 3.0 | 14.9 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 3.0 | 26.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 2.9 | 90.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 2.9 | 5.8 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 2.9 | 2.9 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 2.9 | 157.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 2.9 | 34.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 2.8 | 51.3 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
| 2.8 | 11.4 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 2.8 | 11.4 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 2.8 | 8.5 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 2.8 | 2.8 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 2.8 | 16.8 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 2.8 | 61.6 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
| 2.8 | 14.0 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 2.8 | 8.3 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 2.8 | 22.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) actin filament-based transport(GO:0099515) |
| 2.7 | 118.1 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 2.7 | 13.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 2.7 | 16.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 2.7 | 27.1 | GO:0090382 | phagosome maturation(GO:0090382) |
| 2.7 | 51.6 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
| 2.7 | 51.5 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 2.7 | 29.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 2.7 | 19.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 2.7 | 8.1 | GO:0051795 | positive regulation of catagen(GO:0051795) |
| 2.7 | 51.0 | GO:0009145 | purine nucleoside triphosphate biosynthetic process(GO:0009145) |
| 2.7 | 2.7 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 2.7 | 21.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 2.7 | 5.3 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 2.7 | 26.6 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 2.7 | 13.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 2.6 | 5.3 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 2.6 | 21.1 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 2.6 | 18.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 2.6 | 7.9 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 2.6 | 5.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 2.6 | 13.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 2.6 | 15.6 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 2.6 | 5.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
| 2.6 | 7.8 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 2.6 | 18.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 2.6 | 7.8 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 2.6 | 10.3 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
| 2.6 | 36.1 | GO:0032060 | bleb assembly(GO:0032060) |
| 2.6 | 2.6 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 2.6 | 33.4 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 2.6 | 10.3 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 2.5 | 53.5 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 2.5 | 15.2 | GO:0051014 | actin filament severing(GO:0051014) |
| 2.5 | 5.1 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
| 2.5 | 10.0 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 2.5 | 12.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 2.5 | 117.4 | GO:0007569 | cell aging(GO:0007569) |
| 2.5 | 7.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 2.5 | 9.9 | GO:0045112 | integrin biosynthetic process(GO:0045112) regulation of endodermal cell differentiation(GO:1903224) |
| 2.5 | 29.5 | GO:0006903 | vesicle targeting(GO:0006903) |
| 2.4 | 7.3 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
| 2.4 | 14.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 2.4 | 19.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 2.4 | 122.9 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 2.4 | 4.7 | GO:0072141 | renal interstitial fibroblast development(GO:0072141) |
| 2.4 | 92.3 | GO:0006414 | translational elongation(GO:0006414) |
| 2.4 | 4.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 2.3 | 2.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 2.3 | 2.3 | GO:2000644 | regulation of receptor catabolic process(GO:2000644) |
| 2.3 | 4.7 | GO:0033197 | response to vitamin E(GO:0033197) |
| 2.3 | 11.6 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 2.3 | 16.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 2.3 | 13.9 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 2.3 | 4.6 | GO:2000520 | positive regulation of mononuclear cell migration(GO:0071677) regulation of immunological synapse formation(GO:2000520) negative regulation of immunological synapse formation(GO:2000521) |
| 2.3 | 2.3 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 2.3 | 32.3 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 2.3 | 41.3 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 2.3 | 25.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 2.3 | 70.7 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
| 2.3 | 9.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 2.3 | 38.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 2.3 | 81.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 2.3 | 11.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 2.3 | 9.0 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 2.2 | 6.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 2.2 | 4.5 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 2.2 | 24.5 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
| 2.2 | 6.6 | GO:1903568 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 2.2 | 41.8 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 2.2 | 28.5 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 2.2 | 4.4 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 2.2 | 2.2 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
| 2.2 | 2.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 2.2 | 8.7 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 2.2 | 8.6 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 2.2 | 2.2 | GO:0060437 | lung growth(GO:0060437) |
| 2.2 | 2.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 2.2 | 45.2 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 2.2 | 17.2 | GO:0044743 | intracellular protein transmembrane import(GO:0044743) establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 2.1 | 23.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 2.1 | 23.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 2.1 | 4.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 2.1 | 21.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 2.1 | 75.6 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 2.1 | 35.7 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
| 2.1 | 22.9 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 2.1 | 10.4 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 2.1 | 6.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 2.1 | 4.1 | GO:1903233 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 2.0 | 36.9 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 2.0 | 4.1 | GO:0051775 | response to redox state(GO:0051775) |
| 2.0 | 6.1 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 2.0 | 4.1 | GO:1904732 | regulation of electron carrier activity(GO:1904732) |
| 2.0 | 4.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 2.0 | 11.9 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 2.0 | 4.0 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 2.0 | 23.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 2.0 | 2.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 2.0 | 2.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 1.9 | 56.3 | GO:0045214 | sarcomere organization(GO:0045214) |
| 1.9 | 89.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
| 1.9 | 17.4 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
| 1.9 | 5.8 | GO:0061724 | lipophagy(GO:0061724) |
| 1.9 | 5.8 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 1.9 | 1.9 | GO:0061443 | endocardial cushion cell differentiation(GO:0061443) |
| 1.9 | 66.0 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 1.9 | 35.8 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
| 1.9 | 17.0 | GO:0042775 | ATP synthesis coupled electron transport(GO:0042773) mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 1.9 | 18.8 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 1.9 | 7.5 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 1.9 | 5.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 1.9 | 3.7 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 1.9 | 1.9 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 1.8 | 24.0 | GO:0031639 | plasminogen activation(GO:0031639) |
| 1.8 | 11.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 1.8 | 1.8 | GO:0006623 | protein targeting to vacuole(GO:0006623) |
| 1.8 | 25.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 1.8 | 1.8 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
| 1.8 | 20.2 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 1.8 | 49.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 1.8 | 5.5 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 1.8 | 5.5 | GO:0035425 | autocrine signaling(GO:0035425) |
| 1.8 | 41.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 1.8 | 14.4 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 1.8 | 14.3 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 1.8 | 33.8 | GO:0051923 | sulfation(GO:0051923) |
| 1.8 | 3.5 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 1.8 | 5.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 1.7 | 38.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 1.7 | 15.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 1.7 | 13.9 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 1.7 | 3.5 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 1.7 | 6.9 | GO:0043921 | modulation by host of viral transcription(GO:0043921) modulation by host of symbiont transcription(GO:0052472) |
| 1.7 | 130.0 | GO:0006364 | rRNA processing(GO:0006364) |
| 1.7 | 3.4 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 1.7 | 5.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 1.7 | 6.8 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 1.7 | 64.4 | GO:0015893 | drug transport(GO:0015893) |
| 1.7 | 10.1 | GO:0032532 | regulation of microvillus length(GO:0032532) |
| 1.7 | 3.4 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 1.7 | 3.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 1.7 | 71.7 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 1.7 | 8.3 | GO:0006573 | valine metabolic process(GO:0006573) |
| 1.7 | 18.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
| 1.7 | 6.6 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
| 1.6 | 8.2 | GO:0014870 | response to muscle inactivity(GO:0014870) |
| 1.6 | 27.9 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 1.6 | 3.3 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 1.6 | 8.1 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 1.6 | 14.7 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
| 1.6 | 1.6 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 1.6 | 66.5 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 1.6 | 100.0 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 1.6 | 19.2 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
| 1.6 | 19.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 1.6 | 31.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 1.6 | 4.7 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 1.6 | 6.3 | GO:0009648 | photoperiodism(GO:0009648) |
| 1.6 | 11.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 1.6 | 9.3 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 1.5 | 7.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 1.5 | 4.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 1.5 | 7.6 | GO:0072553 | terminal button organization(GO:0072553) |
| 1.5 | 13.7 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 1.5 | 21.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 1.5 | 13.7 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
| 1.5 | 7.6 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 1.5 | 9.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 1.5 | 21.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 1.5 | 4.5 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 1.5 | 22.4 | GO:0031648 | protein destabilization(GO:0031648) |
| 1.5 | 16.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
| 1.5 | 2.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 1.5 | 42.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 1.4 | 1.4 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 1.4 | 8.5 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 1.4 | 203.1 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
| 1.4 | 11.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 1.4 | 44.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 1.4 | 4.2 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
| 1.4 | 4.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 1.4 | 5.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 1.4 | 9.6 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 1.4 | 2.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 1.4 | 5.4 | GO:0019532 | oxalate transport(GO:0019532) |
| 1.3 | 8.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 1.3 | 4.0 | GO:0097264 | self proteolysis(GO:0097264) |
| 1.3 | 14.7 | GO:0016180 | snRNA processing(GO:0016180) |
| 1.3 | 6.7 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 1.3 | 6.7 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
| 1.3 | 4.0 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 1.3 | 4.0 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 1.3 | 1.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 1.3 | 1.3 | GO:0061009 | common bile duct development(GO:0061009) |
| 1.3 | 1.3 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
| 1.3 | 16.8 | GO:0001909 | leukocyte mediated cytotoxicity(GO:0001909) |
| 1.3 | 24.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 1.3 | 2.6 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 1.3 | 39.7 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 1.3 | 2.5 | GO:0048840 | otolith development(GO:0048840) |
| 1.3 | 5.1 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 1.3 | 2.5 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
| 1.2 | 3.7 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
| 1.2 | 11.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 1.2 | 6.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 1.2 | 1.2 | GO:0045091 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 1.2 | 6.0 | GO:0044531 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
| 1.2 | 1.2 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 1.2 | 1.2 | GO:0060166 | olfactory pit development(GO:0060166) |
| 1.2 | 5.8 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 1.1 | 31.0 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
| 1.1 | 16.0 | GO:0090224 | regulation of spindle organization(GO:0090224) |
| 1.1 | 1.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 1.1 | 3.4 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 1.1 | 7.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 1.1 | 6.7 | GO:0051189 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 1.1 | 3.2 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
| 1.1 | 4.3 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 1.1 | 61.9 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 1.1 | 2.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 1.0 | 1.0 | GO:0007343 | egg activation(GO:0007343) |
| 1.0 | 5.2 | GO:0045006 | DNA deamination(GO:0045006) |
| 1.0 | 6.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 1.0 | 3.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 1.0 | 2.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
| 1.0 | 28.9 | GO:0017144 | drug metabolic process(GO:0017144) |
| 1.0 | 5.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 1.0 | 1.0 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 1.0 | 3.8 | GO:0071888 | macrophage apoptotic process(GO:0071888) |
| 0.9 | 2.8 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.9 | 2.8 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
| 0.9 | 10.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
| 0.9 | 0.9 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
| 0.9 | 2.8 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.9 | 4.6 | GO:1903027 | regulation of opsonization(GO:1903027) |
| 0.9 | 12.0 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
| 0.9 | 5.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.9 | 2.7 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.9 | 5.4 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
| 0.9 | 4.4 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.9 | 9.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.9 | 3.4 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.9 | 0.9 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.8 | 7.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.8 | 2.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.8 | 3.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.8 | 31.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.8 | 29.4 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.8 | 14.6 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
| 0.8 | 8.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.8 | 15.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.8 | 13.4 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.8 | 42.7 | GO:0006413 | translational initiation(GO:0006413) |
| 0.8 | 2.3 | GO:0036233 | glycine import(GO:0036233) |
| 0.8 | 4.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.8 | 0.8 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.8 | 14.3 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.7 | 5.2 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.7 | 6.7 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.7 | 3.7 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.7 | 12.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.7 | 1.4 | GO:0006595 | polyamine metabolic process(GO:0006595) |
| 0.7 | 1.4 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.7 | 2.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.7 | 4.1 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.6 | 3.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.6 | 7.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.6 | 1.9 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
| 0.6 | 1.3 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
| 0.6 | 7.0 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.6 | 4.3 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.6 | 0.6 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
| 0.6 | 1.2 | GO:0021764 | amygdala development(GO:0021764) |
| 0.6 | 4.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.6 | 5.4 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.6 | 5.4 | GO:0009309 | amine biosynthetic process(GO:0009309) |
| 0.6 | 1.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.6 | 2.4 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.6 | 3.5 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
| 0.6 | 4.7 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
| 0.6 | 4.6 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.6 | 5.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.6 | 11.9 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.6 | 7.9 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.6 | 2.2 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.5 | 1.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
| 0.5 | 2.2 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.5 | 13.7 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
| 0.5 | 41.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.5 | 1.5 | GO:0032759 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.5 | 1.4 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.5 | 12.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.5 | 1.9 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.5 | 9.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.5 | 2.3 | GO:0007619 | courtship behavior(GO:0007619) |
| 0.5 | 0.9 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
| 0.5 | 1.8 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.4 | 1.8 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
| 0.4 | 3.5 | GO:0048596 | embryonic camera-type eye morphogenesis(GO:0048596) |
| 0.4 | 2.6 | GO:0002353 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.4 | 0.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.4 | 0.8 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.4 | 5.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.4 | 1.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.4 | 1.6 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.4 | 1.6 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
| 0.4 | 5.3 | GO:0006739 | NADP metabolic process(GO:0006739) |
| 0.4 | 1.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.3 | 3.1 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
| 0.3 | 1.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.3 | 1.0 | GO:0035048 | splicing factor protein import into nucleus(GO:0035048) |
| 0.3 | 0.6 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.3 | 0.3 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.3 | 2.1 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.3 | 9.0 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.3 | 1.1 | GO:0001878 | response to yeast(GO:0001878) |
| 0.3 | 0.8 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.3 | 0.3 | GO:0006113 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 0.3 | 1.5 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
| 0.2 | 1.2 | GO:0002208 | somatic recombination of immunoglobulin genes involved in immune response(GO:0002204) somatic diversification of immunoglobulins involved in immune response(GO:0002208) isotype switching(GO:0045190) |
| 0.2 | 1.0 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.2 | 0.9 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.2 | 0.4 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.2 | 1.0 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.2 | 2.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 | 0.2 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
| 0.2 | 0.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.2 | 0.2 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
| 0.2 | 0.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.2 | 0.5 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 0.2 | 0.5 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.2 | 0.3 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.2 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
| 0.2 | 1.9 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.2 | 0.8 | GO:0046688 | response to copper ion(GO:0046688) |
| 0.2 | 1.4 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.2 | 2.3 | GO:0030811 | regulation of nucleotide catabolic process(GO:0030811) |
| 0.1 | 0.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.1 | 0.4 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
| 0.1 | 0.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.1 | 2.7 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.1 | 4.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 0.5 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 | 0.4 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.1 | 1.1 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 | 2.0 | GO:0046034 | ATP metabolic process(GO:0046034) |
| 0.1 | 1.1 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.1 | 4.9 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 | 0.3 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.1 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.1 | 0.6 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
| 0.1 | 0.4 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.1 | 0.8 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.1 | 0.5 | GO:1990776 | response to angiotensin(GO:1990776) |
| 0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.1 | 0.3 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.0 | 0.1 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.0 | 0.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.0 | 0.0 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.0 | 0.0 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 54.9 | 164.6 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 43.2 | 345.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 34.7 | 207.9 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 28.3 | 113.2 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 28.1 | 168.5 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 28.0 | 139.9 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 27.5 | 109.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 27.3 | 136.4 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 25.6 | 128.1 | GO:0033503 | HULC complex(GO:0033503) |
| 25.0 | 150.3 | GO:0097422 | tubular endosome(GO:0097422) |
| 24.0 | 96.0 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 22.8 | 91.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 22.5 | 90.1 | GO:0071817 | MMXD complex(GO:0071817) |
| 22.2 | 222.0 | GO:0097255 | R2TP complex(GO:0097255) |
| 21.4 | 257.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 21.3 | 106.7 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 21.0 | 147.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 20.7 | 186.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 19.8 | 218.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 19.2 | 57.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 18.8 | 93.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 18.2 | 109.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 17.8 | 106.9 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 17.7 | 17.7 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 17.6 | 87.9 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 17.6 | 123.0 | GO:0090661 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 17.6 | 175.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 17.5 | 192.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 17.3 | 52.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 17.3 | 69.3 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 17.3 | 138.2 | GO:0000796 | condensin complex(GO:0000796) |
| 17.1 | 136.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 16.9 | 135.1 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 16.8 | 67.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 16.8 | 251.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 16.7 | 317.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 16.7 | 83.5 | GO:0031523 | Myb complex(GO:0031523) |
| 16.4 | 16.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 16.2 | 48.6 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 15.7 | 63.0 | GO:0071942 | XPC complex(GO:0071942) |
| 15.7 | 440.3 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 15.7 | 219.2 | GO:0090543 | Flemming body(GO:0090543) |
| 15.2 | 45.7 | GO:1990917 | sperm head plasma membrane(GO:1990913) ooplasm(GO:1990917) |
| 14.8 | 14.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 14.6 | 58.4 | GO:0000811 | GINS complex(GO:0000811) |
| 14.6 | 131.3 | GO:0042382 | paraspeckles(GO:0042382) |
| 14.6 | 174.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 14.4 | 43.2 | GO:0044393 | microspike(GO:0044393) |
| 14.3 | 85.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 14.2 | 57.0 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 14.2 | 70.8 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 13.9 | 237.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 13.9 | 13.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 13.9 | 139.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 13.9 | 83.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 13.9 | 97.3 | GO:0032021 | NELF complex(GO:0032021) |
| 13.8 | 41.4 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 13.8 | 69.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 13.6 | 95.4 | GO:0016589 | NURF complex(GO:0016589) |
| 13.6 | 149.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 13.5 | 188.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 13.4 | 120.7 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 13.4 | 214.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 13.3 | 13.3 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 12.9 | 206.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 12.9 | 218.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 12.7 | 63.7 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 12.7 | 89.0 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 12.6 | 377.4 | GO:0031143 | pseudopodium(GO:0031143) |
| 12.5 | 50.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 12.5 | 175.6 | GO:0070938 | contractile ring(GO:0070938) |
| 12.5 | 50.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 12.5 | 87.6 | GO:0016272 | prefoldin complex(GO:0016272) |
| 12.3 | 37.0 | GO:0030677 | ribonuclease P complex(GO:0030677) |
| 12.3 | 12.3 | GO:0089701 | U2AF(GO:0089701) |
| 12.3 | 12.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 12.1 | 182.0 | GO:0034709 | methylosome(GO:0034709) |
| 12.1 | 60.4 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 12.0 | 168.5 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 12.0 | 203.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 11.8 | 11.8 | GO:0044308 | axonal spine(GO:0044308) |
| 11.6 | 57.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 11.4 | 34.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 11.3 | 56.6 | GO:0001651 | dense fibrillar component(GO:0001651) |
| 11.3 | 236.9 | GO:0032433 | filopodium tip(GO:0032433) |
| 10.7 | 42.8 | GO:0071986 | Ragulator complex(GO:0071986) |
| 10.7 | 21.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 10.7 | 309.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 10.7 | 106.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 10.6 | 84.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 10.6 | 169.7 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 10.5 | 21.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 10.4 | 135.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 10.2 | 10.2 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 10.1 | 71.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 10.1 | 30.2 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 10.0 | 50.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 9.9 | 278.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 9.8 | 68.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 9.8 | 19.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 9.7 | 58.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 9.7 | 67.6 | GO:0031415 | NatA complex(GO:0031415) |
| 9.7 | 77.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 9.6 | 47.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 9.6 | 105.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 9.4 | 103.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 9.4 | 74.8 | GO:0005688 | U6 snRNP(GO:0005688) |
| 9.3 | 28.0 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 9.3 | 55.5 | GO:0071797 | LUBAC complex(GO:0071797) |
| 9.2 | 55.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 9.2 | 359.5 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 9.2 | 36.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 9.1 | 27.4 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 9.1 | 45.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 8.9 | 53.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 8.8 | 8.8 | GO:1990246 | uniplex complex(GO:1990246) |
| 8.7 | 95.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 8.6 | 25.9 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 8.5 | 8.5 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 8.4 | 75.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 8.4 | 242.5 | GO:0000502 | proteasome complex(GO:0000502) |
| 8.3 | 8.3 | GO:0035061 | interchromatin granule(GO:0035061) |
| 8.3 | 24.9 | GO:0097409 | glial cytoplasmic inclusion(GO:0097409) classical Lewy body(GO:0097414) Lewy neurite(GO:0097462) Lewy body corona(GO:1990038) |
| 8.2 | 24.7 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 8.2 | 16.3 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 8.1 | 48.6 | GO:0000125 | PCAF complex(GO:0000125) |
| 8.1 | 97.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 8.1 | 56.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 8.0 | 232.8 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 8.0 | 24.0 | GO:0097441 | basilar dendrite(GO:0097441) |
| 8.0 | 71.7 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 8.0 | 15.9 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 7.9 | 23.7 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 7.8 | 258.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 7.8 | 31.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 7.8 | 38.9 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 7.7 | 68.9 | GO:0044754 | autolysosome(GO:0044754) |
| 7.6 | 160.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 7.6 | 53.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 7.6 | 1164.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 7.6 | 129.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 7.6 | 197.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 7.6 | 106.0 | GO:0005642 | annulate lamellae(GO:0005642) |
| 7.4 | 37.2 | GO:0043291 | RAVE complex(GO:0043291) |
| 7.4 | 37.2 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
| 7.4 | 96.1 | GO:0042555 | MCM complex(GO:0042555) |
| 7.4 | 36.9 | GO:0032449 | CBM complex(GO:0032449) |
| 7.3 | 29.3 | GO:0048179 | activin receptor complex(GO:0048179) |
| 7.3 | 29.3 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 7.3 | 14.6 | GO:0030689 | Noc complex(GO:0030689) |
| 7.3 | 58.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 7.3 | 364.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 7.2 | 245.4 | GO:0071564 | npBAF complex(GO:0071564) |
| 7.2 | 129.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 7.2 | 115.1 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 7.1 | 213.2 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
| 7.0 | 28.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 7.0 | 13.9 | GO:1990423 | RZZ complex(GO:1990423) |
| 6.9 | 34.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 6.9 | 20.8 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 6.8 | 27.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 6.8 | 54.3 | GO:0016600 | flotillin complex(GO:0016600) |
| 6.8 | 6.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 6.8 | 6.8 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 6.7 | 20.2 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 6.7 | 106.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 6.6 | 79.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 6.6 | 53.0 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 6.5 | 58.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 6.5 | 1034.0 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 6.5 | 6.5 | GO:0097342 | ripoptosome(GO:0097342) |
| 6.4 | 365.8 | GO:0005876 | spindle microtubule(GO:0005876) |
| 6.3 | 25.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 6.3 | 6.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 6.3 | 69.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 6.3 | 106.5 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 6.2 | 43.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 6.2 | 6.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 6.1 | 73.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 6.1 | 73.1 | GO:0030008 | TRAPP complex(GO:0030008) |
| 6.0 | 6.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 5.9 | 177.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 5.8 | 128.1 | GO:0030056 | hemidesmosome(GO:0030056) |
| 5.8 | 40.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
| 5.8 | 80.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 5.7 | 34.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 5.7 | 164.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 5.7 | 28.3 | GO:0001940 | male pronucleus(GO:0001940) |
| 5.6 | 33.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 5.6 | 33.7 | GO:1990357 | terminal web(GO:1990357) |
| 5.6 | 39.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 5.6 | 44.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 5.6 | 50.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 5.6 | 61.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 5.5 | 481.9 | GO:0000776 | kinetochore(GO:0000776) |
| 5.5 | 60.8 | GO:0005638 | lamin filament(GO:0005638) |
| 5.5 | 60.6 | GO:0097470 | ribbon synapse(GO:0097470) |
| 5.5 | 5.5 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 5.5 | 5.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 5.4 | 318.0 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 5.4 | 16.1 | GO:0018444 | translation release factor complex(GO:0018444) |
| 5.3 | 21.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 5.3 | 47.5 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 5.3 | 99.8 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 5.2 | 62.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 5.2 | 119.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 5.1 | 15.4 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 5.1 | 25.6 | GO:0030904 | retromer complex(GO:0030904) |
| 5.1 | 15.3 | GO:0035517 | PR-DUB complex(GO:0035517) |
| 5.1 | 25.3 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 5.0 | 986.3 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 5.0 | 20.0 | GO:0097452 | GAIT complex(GO:0097452) |
| 5.0 | 64.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 4.9 | 19.8 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
| 4.9 | 98.7 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 4.9 | 14.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 4.8 | 38.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 4.8 | 4.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 4.8 | 52.8 | GO:0000124 | SAGA complex(GO:0000124) |
| 4.8 | 76.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 4.7 | 23.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 4.7 | 42.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 4.7 | 150.3 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 4.7 | 435.5 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 4.7 | 28.0 | GO:0005955 | calcineurin complex(GO:0005955) |
| 4.6 | 2643.1 | GO:0005925 | focal adhesion(GO:0005925) |
| 4.6 | 9.2 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 4.6 | 50.4 | GO:0070449 | elongin complex(GO:0070449) |
| 4.6 | 27.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 4.5 | 13.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 4.5 | 17.9 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 4.4 | 39.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 4.4 | 13.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 4.4 | 13.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 4.3 | 251.5 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 4.3 | 4.3 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 4.2 | 20.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 4.2 | 166.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 4.1 | 28.4 | GO:0097413 | Lewy body(GO:0097413) |
| 4.1 | 133.8 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
| 4.1 | 300.0 | GO:0005811 | lipid particle(GO:0005811) |
| 4.1 | 32.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 4.0 | 28.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 4.0 | 32.3 | GO:0070652 | HAUS complex(GO:0070652) |
| 4.0 | 16.2 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 4.0 | 12.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 3.9 | 51.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 3.9 | 31.2 | GO:0031209 | SCAR complex(GO:0031209) |
| 3.9 | 23.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 3.8 | 15.0 | GO:0044307 | dendritic branch(GO:0044307) |
| 3.7 | 18.7 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 3.7 | 22.1 | GO:0070552 | BRISC complex(GO:0070552) |
| 3.7 | 43.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 3.6 | 46.6 | GO:0043073 | germ cell nucleus(GO:0043073) |
| 3.6 | 17.9 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 3.6 | 14.3 | GO:0030891 | VCB complex(GO:0030891) |
| 3.5 | 24.7 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
| 3.5 | 21.0 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 3.5 | 35.0 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 3.5 | 7.0 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 3.5 | 299.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 3.5 | 10.4 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 3.4 | 27.6 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 3.4 | 6.8 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 3.4 | 23.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 3.3 | 26.7 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
| 3.3 | 3.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 3.2 | 81.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 3.2 | 6.5 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 3.2 | 61.1 | GO:0044391 | ribosomal subunit(GO:0044391) |
| 3.2 | 112.5 | GO:0043034 | costamere(GO:0043034) |
| 3.2 | 9.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 3.2 | 22.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 3.1 | 40.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 3.1 | 31.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 3.1 | 12.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 3.0 | 54.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 3.0 | 23.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 3.0 | 62.2 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 2.9 | 8.7 | GO:1990393 | 3M complex(GO:1990393) |
| 2.9 | 26.1 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 2.9 | 106.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 2.8 | 152.7 | GO:0035580 | specific granule lumen(GO:0035580) |
| 2.8 | 19.7 | GO:0008091 | spectrin(GO:0008091) |
| 2.8 | 22.4 | GO:0070187 | telosome(GO:0070187) |
| 2.8 | 170.6 | GO:0005643 | nuclear pore(GO:0005643) |
| 2.8 | 77.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 2.8 | 8.3 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 2.8 | 16.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 2.7 | 24.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 2.7 | 232.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 2.7 | 53.3 | GO:0035861 | site of double-strand break(GO:0035861) |
| 2.7 | 39.9 | GO:0070469 | respiratory chain(GO:0070469) |
| 2.6 | 13.2 | GO:0001739 | sex chromatin(GO:0001739) |
| 2.6 | 37.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 2.6 | 576.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 2.6 | 5.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 2.6 | 5.2 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 2.6 | 118.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 2.5 | 2.5 | GO:1990462 | omegasome(GO:1990462) |
| 2.5 | 17.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 2.5 | 2.5 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
| 2.5 | 2.5 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 2.5 | 22.2 | GO:0051233 | spindle midzone(GO:0051233) |
| 2.5 | 12.3 | GO:0032044 | DSIF complex(GO:0032044) |
| 2.4 | 63.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 2.4 | 2.4 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 2.4 | 19.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 2.4 | 77.1 | GO:0005605 | basal lamina(GO:0005605) |
| 2.4 | 18.9 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 2.3 | 4.7 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 2.3 | 27.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 2.3 | 6.8 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 2.3 | 20.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 2.2 | 6.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 2.2 | 8.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 2.2 | 39.7 | GO:0038201 | TOR complex(GO:0038201) |
| 2.2 | 70.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 2.2 | 91.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 2.2 | 95.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 2.1 | 265.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 2.1 | 4.3 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 2.1 | 29.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 2.1 | 58.8 | GO:0031526 | brush border membrane(GO:0031526) |
| 2.1 | 18.9 | GO:0032059 | bleb(GO:0032059) |
| 2.1 | 31.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 2.1 | 26.8 | GO:0000812 | Swr1 complex(GO:0000812) |
| 2.0 | 8.0 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 2.0 | 2.0 | GO:0000805 | X chromosome(GO:0000805) |
| 1.9 | 9.7 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
| 1.9 | 11.7 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 1.9 | 514.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 1.9 | 92.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 1.9 | 26.7 | GO:0001891 | phagocytic cup(GO:0001891) |
| 1.9 | 19.0 | GO:0070852 | cell body fiber(GO:0070852) |
| 1.9 | 5.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 1.8 | 14.8 | GO:0030686 | 90S preribosome(GO:0030686) |
| 1.8 | 7.3 | GO:0035363 | histone locus body(GO:0035363) |
| 1.7 | 16.9 | GO:0061574 | ASAP complex(GO:0061574) |
| 1.7 | 3.3 | GO:0055087 | Ski complex(GO:0055087) |
| 1.6 | 4.9 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 1.6 | 50.3 | GO:0032420 | stereocilium(GO:0032420) |
| 1.6 | 13.0 | GO:0071203 | WASH complex(GO:0071203) |
| 1.6 | 22.6 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 1.6 | 16.1 | GO:0036452 | ESCRT complex(GO:0036452) |
| 1.6 | 3.2 | GO:0005869 | dynactin complex(GO:0005869) |
| 1.6 | 1.6 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 1.6 | 1.6 | GO:0071920 | cleavage body(GO:0071920) |
| 1.5 | 109.3 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 1.5 | 7.6 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 1.5 | 4.6 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 1.5 | 98.3 | GO:0000793 | condensed chromosome(GO:0000793) |
| 1.5 | 43.2 | GO:0045178 | basal part of cell(GO:0045178) |
| 1.5 | 7.3 | GO:0010369 | chromocenter(GO:0010369) |
| 1.4 | 4.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 1.4 | 15.5 | GO:0097346 | INO80-type complex(GO:0097346) |
| 1.4 | 7.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 1.4 | 2.8 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 1.4 | 2.7 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 1.4 | 8.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 1.3 | 1.3 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 1.3 | 14.7 | GO:0032039 | integrator complex(GO:0032039) |
| 1.3 | 3286.5 | GO:0070062 | extracellular exosome(GO:0070062) |
| 1.3 | 19.9 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 1.3 | 5.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 1.3 | 22.8 | GO:0032432 | actin filament bundle(GO:0032432) |
| 1.3 | 2.5 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 1.2 | 52.6 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
| 1.2 | 17.4 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 1.1 | 117.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 1.1 | 4.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 1.0 | 41.9 | GO:0030496 | midbody(GO:0030496) |
| 1.0 | 6.7 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
| 0.9 | 4.6 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
| 0.9 | 9.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.9 | 16.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.8 | 4.7 | GO:0002102 | podosome(GO:0002102) |
| 0.7 | 2.2 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.7 | 18.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.7 | 14.3 | GO:0005861 | troponin complex(GO:0005861) |
| 0.7 | 4.6 | GO:0032797 | SMN complex(GO:0032797) |
| 0.6 | 4.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.6 | 1.8 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.6 | 3.0 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.5 | 3.5 | GO:0042641 | actomyosin(GO:0042641) |
| 0.5 | 2.9 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.5 | 13.4 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.4 | 11.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.4 | 7.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.4 | 0.7 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 0.4 | 2.1 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 0.3 | 0.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.3 | 32.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.3 | 1.0 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.3 | 1.3 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.2 | 1.6 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.2 | 2.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.2 | 14.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.1 | 0.6 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 12.0 | GO:0005819 | spindle(GO:0005819) |
| 0.1 | 0.3 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.1 | 0.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 43.2 | 345.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 39.9 | 119.7 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 38.1 | 114.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 36.5 | 109.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 36.0 | 108.0 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 35.9 | 143.5 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 35.3 | 176.4 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 34.4 | 103.2 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
| 34.0 | 136.2 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 33.7 | 168.5 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 32.9 | 164.6 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 31.7 | 95.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 31.1 | 93.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 30.1 | 150.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 29.6 | 207.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 28.7 | 86.2 | GO:0004639 | phosphoribosylaminoimidazole carboxylase activity(GO:0004638) phosphoribosylaminoimidazolesuccinocarboxamide synthase activity(GO:0004639) |
| 28.7 | 86.1 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 27.7 | 166.3 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 27.5 | 109.9 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 27.1 | 81.3 | GO:0047315 | kynurenine-glyoxylate transaminase activity(GO:0047315) |
| 26.4 | 79.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 26.3 | 78.8 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 26.1 | 104.5 | GO:0004802 | transketolase activity(GO:0004802) |
| 25.5 | 76.4 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 25.4 | 152.3 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 24.8 | 74.4 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 24.7 | 74.2 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 24.6 | 98.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 24.3 | 146.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 24.3 | 72.9 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 24.2 | 72.7 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 24.1 | 72.3 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 23.6 | 94.5 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 22.5 | 67.4 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 22.4 | 67.2 | GO:0031403 | lithium ion binding(GO:0031403) |
| 22.3 | 156.1 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 22.1 | 88.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 22.0 | 88.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 21.9 | 131.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 21.8 | 65.3 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 21.6 | 172.9 | GO:0015288 | porin activity(GO:0015288) |
| 21.4 | 149.7 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 21.4 | 64.1 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 20.9 | 62.7 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 20.8 | 62.5 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 20.8 | 62.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 20.8 | 290.7 | GO:0031386 | protein tag(GO:0031386) |
| 20.7 | 62.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 20.5 | 81.8 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
| 20.4 | 203.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 20.3 | 81.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 20.0 | 20.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 20.0 | 119.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 19.4 | 135.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 19.0 | 57.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 19.0 | 57.0 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 18.1 | 108.9 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 18.1 | 180.6 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 17.9 | 71.5 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 17.6 | 123.4 | GO:0005497 | androgen binding(GO:0005497) |
| 17.6 | 123.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 17.5 | 227.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 17.3 | 104.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 17.3 | 69.3 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
| 17.3 | 51.9 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 17.2 | 223.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 17.0 | 118.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 16.9 | 67.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 16.9 | 84.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
| 16.8 | 50.5 | GO:0047012 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity(GO:0047012) |
| 16.6 | 66.4 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 16.6 | 66.4 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 16.6 | 49.7 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
| 16.3 | 48.8 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 16.2 | 65.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 16.2 | 129.7 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 15.8 | 63.3 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 15.8 | 63.2 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 15.8 | 142.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 15.6 | 62.5 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 15.5 | 93.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
| 15.5 | 46.4 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 15.2 | 60.7 | GO:0042282 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
| 14.7 | 411.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 14.7 | 161.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 14.6 | 87.7 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 14.6 | 102.2 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
| 14.6 | 58.4 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 14.5 | 72.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 14.4 | 14.4 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 14.3 | 42.8 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
| 14.2 | 71.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 14.1 | 56.5 | GO:0043515 | kinetochore binding(GO:0043515) |
| 14.0 | 168.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 13.9 | 249.3 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 13.8 | 41.4 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 13.7 | 95.9 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 13.4 | 120.7 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 13.4 | 214.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 13.3 | 39.8 | GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity(GO:0003860) |
| 13.3 | 92.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 13.3 | 106.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 13.2 | 13.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 13.2 | 52.7 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
| 13.1 | 78.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 13.1 | 39.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 12.9 | 51.7 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 12.9 | 64.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 12.8 | 153.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 12.8 | 38.3 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 12.7 | 51.0 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 12.6 | 352.6 | GO:0017166 | vinculin binding(GO:0017166) |
| 12.6 | 50.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 12.4 | 37.3 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 12.3 | 49.3 | GO:0070513 | death domain binding(GO:0070513) |
| 12.3 | 12.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 12.2 | 49.0 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 12.2 | 48.9 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 12.1 | 72.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 12.0 | 59.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 12.0 | 47.8 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
| 11.9 | 23.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
| 11.9 | 47.6 | GO:0070404 | NADH binding(GO:0070404) |
| 11.8 | 283.8 | GO:0070628 | proteasome binding(GO:0070628) |
| 11.7 | 35.1 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 11.7 | 58.4 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 11.6 | 92.9 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 11.6 | 23.2 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 11.6 | 69.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 11.6 | 46.3 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 11.5 | 103.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 11.5 | 80.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 11.4 | 11.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 11.4 | 514.1 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 11.3 | 22.6 | GO:0046979 | TAP2 binding(GO:0046979) |
| 11.3 | 79.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 11.2 | 33.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 11.2 | 101.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 11.0 | 44.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 10.9 | 283.3 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 10.9 | 65.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 10.9 | 10.9 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
| 10.7 | 74.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 10.7 | 181.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 10.6 | 31.9 | GO:0048030 | disaccharide binding(GO:0048030) |
| 10.6 | 31.9 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 10.5 | 31.4 | GO:0070025 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 10.4 | 31.3 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 10.3 | 196.1 | GO:0043495 | protein anchor(GO:0043495) |
| 10.3 | 61.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 10.2 | 112.4 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 10.2 | 61.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 10.2 | 10.2 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
| 10.2 | 30.5 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 10.1 | 302.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 10.1 | 20.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 9.9 | 39.7 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 9.9 | 29.7 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 9.7 | 58.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 9.6 | 48.2 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 9.6 | 28.9 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 9.6 | 86.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 9.4 | 28.3 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 9.4 | 37.5 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 9.4 | 37.5 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 9.4 | 28.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 9.4 | 28.1 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 9.3 | 37.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 9.3 | 27.9 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 9.3 | 46.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 9.3 | 9.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 9.3 | 46.3 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 9.2 | 27.6 | GO:1903135 | cupric ion binding(GO:1903135) |
| 9.1 | 128.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 9.1 | 81.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 9.0 | 117.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 9.0 | 9.0 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 9.0 | 17.9 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 9.0 | 62.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 8.9 | 35.6 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 8.8 | 43.9 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 8.8 | 26.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 8.8 | 8.8 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) |
| 8.8 | 26.3 | GO:0000248 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
| 8.7 | 96.0 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 8.7 | 87.2 | GO:0042731 | PH domain binding(GO:0042731) |
| 8.6 | 25.9 | GO:0035730 | S-nitrosoglutathione binding(GO:0035730) dinitrosyl-iron complex binding(GO:0035731) |
| 8.6 | 222.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 8.5 | 221.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 8.5 | 42.4 | GO:0097617 | annealing activity(GO:0097617) |
| 8.4 | 33.8 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
| 8.4 | 75.9 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 8.4 | 16.8 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
| 8.3 | 8.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 8.3 | 24.8 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 8.2 | 197.9 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 8.2 | 8.2 | GO:0032810 | sterol response element binding(GO:0032810) |
| 8.2 | 24.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 8.1 | 32.2 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 8.0 | 47.9 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 7.9 | 31.7 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 7.9 | 47.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 7.9 | 284.4 | GO:0008143 | poly(A) binding(GO:0008143) |
| 7.9 | 31.5 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 7.8 | 595.4 | GO:0019003 | GDP binding(GO:0019003) |
| 7.8 | 7.8 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 7.8 | 85.8 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 7.8 | 15.6 | GO:0055100 | adiponectin binding(GO:0055100) |
| 7.8 | 31.1 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 7.8 | 38.9 | GO:0032143 | single thymine insertion binding(GO:0032143) |
| 7.7 | 77.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 7.7 | 23.0 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
| 7.6 | 76.5 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 7.6 | 30.5 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 7.6 | 30.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 7.6 | 38.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 7.5 | 37.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 7.5 | 22.6 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
| 7.5 | 15.1 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
| 7.5 | 7.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 7.5 | 7.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 7.5 | 44.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 7.5 | 37.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 7.4 | 51.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 7.3 | 29.4 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
| 7.3 | 117.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 7.3 | 44.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 7.3 | 14.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 7.3 | 21.9 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 7.3 | 21.9 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 7.3 | 262.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 7.2 | 21.7 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
| 7.2 | 72.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 7.2 | 129.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 7.1 | 21.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 7.1 | 7.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 7.1 | 85.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 7.1 | 21.2 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
| 7.0 | 56.1 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 6.9 | 13.8 | GO:0043398 | HLH domain binding(GO:0043398) |
| 6.9 | 41.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 6.9 | 55.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 6.9 | 27.5 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 6.9 | 6.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 6.8 | 27.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 6.8 | 34.2 | GO:0016936 | galactoside binding(GO:0016936) |
| 6.8 | 211.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 6.8 | 20.4 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
| 6.8 | 108.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 6.8 | 13.5 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 6.7 | 20.2 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
| 6.7 | 53.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 6.7 | 161.8 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 6.7 | 67.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 6.7 | 220.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 6.7 | 46.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
| 6.7 | 26.7 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) procollagen-proline dioxygenase activity(GO:0019798) |
| 6.7 | 20.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 6.6 | 19.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 6.6 | 46.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 6.6 | 72.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 6.6 | 26.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 6.6 | 19.7 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 6.6 | 19.7 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
| 6.5 | 32.6 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 6.5 | 103.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 6.5 | 77.8 | GO:0000339 | RNA cap binding(GO:0000339) |
| 6.5 | 45.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 6.4 | 64.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 6.4 | 127.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 6.4 | 95.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 6.3 | 76.0 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
| 6.3 | 38.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 6.3 | 43.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 6.2 | 12.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 6.2 | 24.6 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 6.2 | 61.5 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 6.2 | 86.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 6.1 | 24.4 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
| 6.1 | 230.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 6.0 | 30.1 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 6.0 | 18.0 | GO:0043035 | chromatin insulator sequence binding(GO:0043035) |
| 6.0 | 30.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 6.0 | 17.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 6.0 | 35.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 6.0 | 35.8 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 6.0 | 285.9 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 5.9 | 5.9 | GO:0034046 | poly(G) binding(GO:0034046) |
| 5.9 | 1240.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 5.9 | 29.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 5.8 | 46.5 | GO:0050733 | RS domain binding(GO:0050733) |
| 5.8 | 340.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 5.7 | 28.7 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 5.7 | 51.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 5.7 | 103.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 5.7 | 108.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 5.7 | 11.4 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 5.7 | 11.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 5.7 | 39.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 5.7 | 272.5 | GO:0050699 | WW domain binding(GO:0050699) |
| 5.7 | 5.7 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 5.6 | 107.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 5.6 | 45.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 5.6 | 22.5 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 5.6 | 50.4 | GO:0089720 | caspase binding(GO:0089720) |
| 5.6 | 16.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 5.6 | 166.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 5.6 | 5.6 | GO:0032427 | GBD domain binding(GO:0032427) |
| 5.5 | 44.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 5.5 | 2177.7 | GO:0045296 | cadherin binding(GO:0045296) |
| 5.4 | 16.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 5.4 | 16.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 5.4 | 32.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 5.3 | 96.3 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 5.3 | 37.4 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 5.3 | 79.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 5.3 | 84.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 5.3 | 21.1 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 5.2 | 21.0 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 5.2 | 31.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 5.2 | 161.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 5.2 | 83.1 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 5.2 | 5.2 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 5.1 | 15.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 5.1 | 51.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 5.1 | 41.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 5.1 | 56.3 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 5.1 | 101.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 5.1 | 5.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 5.1 | 50.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 5.1 | 30.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 5.0 | 20.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 5.0 | 105.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 5.0 | 140.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 5.0 | 75.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 5.0 | 15.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 5.0 | 49.9 | GO:0050692 | DBD domain binding(GO:0050692) |
| 5.0 | 14.9 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
| 5.0 | 119.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 5.0 | 119.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 5.0 | 24.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 4.9 | 123.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 4.9 | 4.9 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
| 4.9 | 29.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 4.9 | 24.3 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 4.9 | 53.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 4.8 | 28.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 4.8 | 9.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 4.8 | 28.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 4.8 | 104.5 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 4.7 | 18.9 | GO:0036033 | mediator complex binding(GO:0036033) |
| 4.7 | 18.8 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 4.7 | 18.8 | GO:0004335 | galactokinase activity(GO:0004335) |
| 4.7 | 14.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 4.7 | 23.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 4.7 | 14.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 4.6 | 4.6 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
| 4.6 | 32.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 4.6 | 4.6 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
| 4.6 | 55.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 4.6 | 36.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 4.6 | 4.6 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
| 4.5 | 95.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 4.5 | 8.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 4.5 | 26.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 4.5 | 8.9 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 4.4 | 39.9 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 4.4 | 8.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 4.4 | 39.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 4.4 | 13.1 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 4.4 | 17.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 4.3 | 12.8 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 4.3 | 59.6 | GO:0031489 | myosin V binding(GO:0031489) |
| 4.2 | 21.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 4.2 | 105.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 4.2 | 12.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 4.2 | 25.0 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 4.2 | 16.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 4.1 | 82.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 4.1 | 28.7 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
| 4.1 | 12.2 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 4.1 | 8.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 4.1 | 77.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 4.0 | 12.1 | GO:0003896 | DNA primase activity(GO:0003896) |
| 4.0 | 20.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 4.0 | 123.5 | GO:0005123 | death receptor binding(GO:0005123) |
| 4.0 | 55.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 3.9 | 15.7 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 3.9 | 3.9 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
| 3.9 | 62.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 3.9 | 38.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 3.8 | 23.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 3.8 | 3.8 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 3.8 | 19.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 3.8 | 11.5 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 3.8 | 15.1 | GO:0070990 | snRNP binding(GO:0070990) |
| 3.7 | 11.2 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 3.7 | 18.7 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 3.7 | 33.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 3.7 | 18.6 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 3.7 | 7.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 3.7 | 11.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 3.7 | 14.8 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 3.7 | 102.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 3.7 | 29.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 3.6 | 21.7 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 3.6 | 57.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 3.6 | 42.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 3.6 | 10.7 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 3.5 | 46.1 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 3.5 | 17.6 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 3.5 | 70.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 3.5 | 10.4 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
| 3.5 | 27.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 3.4 | 27.6 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 3.4 | 488.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 3.4 | 27.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 3.4 | 57.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 3.4 | 13.6 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
| 3.4 | 16.9 | GO:0097016 | L27 domain binding(GO:0097016) |
| 3.4 | 50.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 3.4 | 107.6 | GO:0043236 | laminin binding(GO:0043236) |
| 3.3 | 23.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 3.3 | 66.0 | GO:0048156 | tau protein binding(GO:0048156) |
| 3.3 | 39.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 3.3 | 19.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 3.3 | 72.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 3.3 | 39.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 3.3 | 3.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 3.2 | 61.5 | GO:0051400 | BH domain binding(GO:0051400) |
| 3.2 | 41.1 | GO:0031491 | nucleosome binding(GO:0031491) |
| 3.2 | 15.8 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 3.2 | 3.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 3.1 | 31.2 | GO:0043295 | glutathione binding(GO:0043295) |
| 3.1 | 9.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 3.1 | 3.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 3.1 | 12.3 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 3.1 | 12.2 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 3.0 | 12.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 3.0 | 12.1 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 3.0 | 12.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 3.0 | 33.3 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
| 3.0 | 60.4 | GO:0003785 | actin monomer binding(GO:0003785) |
| 3.0 | 6.0 | GO:0048256 | flap endonuclease activity(GO:0048256) |
| 3.0 | 104.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 3.0 | 47.7 | GO:0008483 | transaminase activity(GO:0008483) |
| 3.0 | 305.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 3.0 | 26.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 3.0 | 50.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 2.9 | 14.7 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 2.9 | 26.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 2.9 | 2.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 2.9 | 55.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 2.9 | 84.1 | GO:0015485 | cholesterol binding(GO:0015485) |
| 2.9 | 11.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 2.9 | 11.5 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 2.9 | 5.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 2.9 | 8.6 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 2.9 | 20.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 2.9 | 11.5 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 2.9 | 17.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 2.8 | 2.8 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
| 2.8 | 11.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 2.8 | 2.8 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 2.7 | 2.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 2.7 | 10.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 2.7 | 27.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 2.7 | 24.0 | GO:0050700 | CARD domain binding(GO:0050700) |
| 2.7 | 10.7 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 2.6 | 15.9 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 2.6 | 13.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 2.6 | 13.0 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 2.6 | 23.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 2.6 | 33.5 | GO:0035173 | histone kinase activity(GO:0035173) |
| 2.6 | 46.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 2.6 | 7.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 2.6 | 10.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 2.5 | 374.7 | GO:0042393 | histone binding(GO:0042393) |
| 2.5 | 10.2 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 2.5 | 175.4 | GO:0009055 | electron carrier activity(GO:0009055) |
| 2.5 | 27.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 2.5 | 379.1 | GO:0005178 | integrin binding(GO:0005178) |
| 2.4 | 12.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 2.4 | 2.4 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 2.4 | 16.7 | GO:0000182 | rDNA binding(GO:0000182) |
| 2.4 | 14.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 2.4 | 38.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 2.4 | 11.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 2.4 | 4.7 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 2.4 | 2.4 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
| 2.4 | 35.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 2.3 | 35.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 2.3 | 14.0 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 2.3 | 60.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 2.3 | 13.9 | GO:0032190 | acrosin binding(GO:0032190) |
| 2.3 | 11.5 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 2.3 | 9.1 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 2.3 | 6.8 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 2.2 | 26.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 2.2 | 9.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 2.2 | 44.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 2.2 | 8.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 2.2 | 59.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 2.2 | 6.6 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 2.2 | 33.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 2.2 | 147.8 | GO:0008565 | protein transporter activity(GO:0008565) |
| 2.2 | 8.8 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 2.2 | 8.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 2.2 | 17.6 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 2.2 | 24.1 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 2.2 | 8.6 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 2.2 | 15.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 2.1 | 27.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 2.1 | 10.7 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 2.1 | 6.4 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 2.1 | 6.4 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 2.1 | 6.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 2.0 | 10.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 2.0 | 4.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
| 2.0 | 47.0 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 2.0 | 109.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 2.0 | 10.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 2.0 | 14.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 2.0 | 21.9 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 2.0 | 2.0 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 2.0 | 9.9 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 2.0 | 73.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 1.9 | 44.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 1.9 | 7.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 1.9 | 21.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 1.9 | 3.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 1.9 | 7.7 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 1.9 | 28.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 1.9 | 5.6 | GO:0015556 | malate transmembrane transporter activity(GO:0015140) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
| 1.9 | 9.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 1.9 | 5.6 | GO:0046577 | long-chain-alcohol oxidase activity(GO:0046577) |
| 1.9 | 22.5 | GO:0030515 | snoRNA binding(GO:0030515) |
| 1.9 | 227.8 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 1.9 | 7.4 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 1.9 | 7.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 1.9 | 1.9 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 1.8 | 57.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 1.8 | 7.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 1.8 | 9.0 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 1.8 | 116.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 1.8 | 46.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 1.8 | 5.4 | GO:0002046 | opsin binding(GO:0002046) |
| 1.8 | 14.2 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 1.7 | 15.7 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 1.7 | 5.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 1.7 | 15.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 1.7 | 6.9 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 1.7 | 10.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 1.7 | 8.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
| 1.7 | 3.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 1.7 | 5.0 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 1.7 | 3.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 1.7 | 43.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 1.6 | 3.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 1.6 | 116.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 1.6 | 30.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 1.6 | 9.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 1.6 | 35.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 1.6 | 9.6 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 1.6 | 11.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 1.6 | 9.6 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 1.6 | 3.2 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 1.6 | 9.5 | GO:0004064 | arylesterase activity(GO:0004064) |
| 1.6 | 15.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 1.5 | 12.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 1.5 | 58.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 1.5 | 12.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 1.5 | 7.6 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 1.5 | 25.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 1.5 | 55.1 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 1.5 | 14.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 1.5 | 30.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 1.5 | 109.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 1.5 | 18.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 1.4 | 11.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 1.4 | 15.7 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
| 1.4 | 7.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 1.4 | 14.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 1.4 | 4.3 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 1.4 | 9.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 1.4 | 8.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 1.4 | 85.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 1.4 | 19.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 1.4 | 5.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 1.3 | 2.7 | GO:0035473 | lipase binding(GO:0035473) |
| 1.3 | 18.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 1.3 | 5.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 1.3 | 7.9 | GO:0030274 | LIM domain binding(GO:0030274) |
| 1.3 | 64.9 | GO:0070888 | E-box binding(GO:0070888) |
| 1.3 | 14.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 1.3 | 3.9 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 1.3 | 25.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 1.3 | 20.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 1.3 | 5.1 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
| 1.3 | 3.8 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 1.3 | 8.8 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 1.3 | 30.1 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 1.2 | 7.5 | GO:0015350 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
| 1.2 | 5.0 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 1.2 | 69.6 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 1.2 | 8.5 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
| 1.2 | 25.2 | GO:0000049 | tRNA binding(GO:0000049) |
| 1.2 | 10.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 1.2 | 13.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 1.2 | 2.3 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 1.1 | 5.7 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
| 1.1 | 5.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 1.1 | 8.9 | GO:0008494 | translation activator activity(GO:0008494) |
| 1.1 | 479.3 | GO:0003712 | transcription cofactor activity(GO:0003712) |
| 1.1 | 15.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 1.1 | 13.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 1.0 | 33.5 | GO:0030332 | cyclin binding(GO:0030332) |
| 1.0 | 97.0 | GO:0002020 | protease binding(GO:0002020) |
| 1.0 | 1.0 | GO:0004314 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
| 1.0 | 21.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 1.0 | 10.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 1.0 | 100.1 | GO:0051015 | actin filament binding(GO:0051015) |
| 1.0 | 2.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 1.0 | 4.9 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.9 | 6.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.9 | 3.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.9 | 5.4 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.9 | 8.1 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.9 | 2.7 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.9 | 42.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.9 | 11.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.9 | 2.6 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.8 | 34.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.8 | 1.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.8 | 4.1 | GO:0050544 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
| 0.8 | 3.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 0.8 | 50.7 | GO:0005518 | collagen binding(GO:0005518) |
| 0.8 | 6.3 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.8 | 49.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.8 | 26.0 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.8 | 19.8 | GO:0071617 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
| 0.8 | 5.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.7 | 123.3 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.7 | 15.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.7 | 3.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.7 | 2.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.7 | 7.7 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.7 | 5.5 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.7 | 4.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.7 | 12.0 | GO:0019239 | deaminase activity(GO:0019239) |
| 0.6 | 632.3 | GO:0003723 | RNA binding(GO:0003723) |
| 0.6 | 7.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.6 | 3.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.6 | 10.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.6 | 4.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.6 | 6.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.5 | 2.2 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.5 | 1.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.5 | 3.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.5 | 1.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 0.5 | 4.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.5 | 1.0 | GO:0038181 | bile acid receptor activity(GO:0038181) vitamin D response element binding(GO:0070644) |
| 0.4 | 1.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.4 | 2.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.4 | 1.3 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.4 | 3.0 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
| 0.4 | 1.3 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.4 | 1.7 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
| 0.4 | 0.8 | GO:0051430 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.3 | 1.4 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.3 | 0.6 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.3 | 3.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.3 | 2.9 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 0.3 | 0.5 | GO:0036505 | prosaposin receptor activity(GO:0036505) |
| 0.3 | 7.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.2 | 2.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.2 | 0.5 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.2 | 0.9 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.2 | 9.4 | GO:0008238 | exopeptidase activity(GO:0008238) |
| 0.2 | 1.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.2 | 2.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.2 | 0.5 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.2 | 18.3 | GO:0008201 | heparin binding(GO:0008201) |
| 0.1 | 0.4 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.1 | 0.4 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.1 | 1.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.1 | 0.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.1 | 0.3 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.1 | 16.1 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
| 0.1 | 0.7 | GO:0005549 | odorant binding(GO:0005549) |
| 0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.1 | 0.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 0.3 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
| 0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.8 | 25.7 | PID IFNG PATHWAY | IFN-gamma pathway |
| 11.2 | 1610.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 10.9 | 142.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 9.9 | 463.6 | PID BARD1 PATHWAY | BARD1 signaling events |
| 9.3 | 509.5 | PID AURORA B PATHWAY | Aurora B signaling |
| 8.9 | 241.3 | PID ARF 3PATHWAY | Arf1 pathway |
| 8.9 | 204.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 8.7 | 286.1 | PID ATM PATHWAY | ATM pathway |
| 8.3 | 382.5 | PID PLK1 PATHWAY | PLK1 signaling events |
| 8.0 | 344.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 7.9 | 15.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 7.8 | 504.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 7.6 | 341.6 | PID ATR PATHWAY | ATR signaling pathway |
| 7.3 | 88.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 7.1 | 353.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 6.8 | 75.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 6.6 | 91.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 6.1 | 12.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 6.0 | 95.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 5.8 | 163.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 5.4 | 391.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 5.1 | 154.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 5.1 | 35.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 5.0 | 423.8 | PID E2F PATHWAY | E2F transcription factor network |
| 4.9 | 281.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 4.8 | 189.1 | PID ALK1 PATHWAY | ALK1 signaling events |
| 4.8 | 135.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 4.4 | 88.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 4.2 | 83.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 4.1 | 114.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 4.0 | 112.3 | PID RHOA PATHWAY | RhoA signaling pathway |
| 4.0 | 108.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 4.0 | 47.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 3.6 | 7.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 3.6 | 233.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 3.5 | 191.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 3.3 | 259.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 3.3 | 168.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 3.2 | 167.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 3.2 | 119.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 3.1 | 81.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 3.1 | 31.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 3.1 | 298.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 3.1 | 94.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 3.0 | 99.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 3.0 | 117.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 3.0 | 89.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 2.9 | 55.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 2.9 | 20.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 2.7 | 83.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 2.6 | 10.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 2.4 | 24.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 2.4 | 131.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 2.4 | 78.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 2.4 | 40.4 | PID IGF1 PATHWAY | IGF1 pathway |
| 2.3 | 37.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 2.3 | 69.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 2.1 | 106.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 2.0 | 18.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 2.0 | 46.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 2.0 | 28.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 2.0 | 19.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 2.0 | 80.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 1.9 | 44.7 | PID FOXO PATHWAY | FoxO family signaling |
| 1.9 | 24.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 1.9 | 110.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 1.9 | 18.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 1.8 | 108.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 1.8 | 70.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 1.7 | 16.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 1.6 | 6.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 1.6 | 23.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 1.5 | 6.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 1.5 | 43.4 | PID P53 REGULATION PATHWAY | p53 pathway |
| 1.4 | 35.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 1.4 | 19.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 1.4 | 61.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 1.2 | 15.8 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 1.1 | 10.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 1.1 | 85.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 1.0 | 6.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.9 | 1.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.8 | 36.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.8 | 19.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.7 | 22.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.7 | 7.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.7 | 4.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.6 | 19.1 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.6 | 4.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.5 | 11.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.5 | 1.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.5 | 8.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.4 | 33.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.4 | 4.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.4 | 16.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.3 | 4.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.3 | 7.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.3 | 2.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.3 | 5.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.2 | 50.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.2 | 2.0 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.2 | 0.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.2 | 2.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 2.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 1.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 18.4 | 590.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 18.4 | 276.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 17.3 | 260.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 16.3 | 538.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 16.0 | 240.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 15.4 | 1121.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 15.3 | 214.3 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 14.5 | 72.6 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
| 14.5 | 159.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 14.3 | 214.3 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 14.2 | 227.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 14.1 | 212.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 13.9 | 457.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 13.6 | 313.9 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 13.6 | 544.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 13.4 | 227.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 13.2 | 144.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 12.9 | 296.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 12.9 | 51.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 12.5 | 350.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 12.2 | 415.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 12.0 | 108.3 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
| 11.5 | 311.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 11.4 | 22.8 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 11.3 | 101.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 11.0 | 175.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 10.7 | 406.8 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 10.5 | 73.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 10.4 | 595.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 10.3 | 61.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 10.3 | 349.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 10.3 | 235.8 | REACTOME S PHASE | Genes involved in S Phase |
| 10.0 | 140.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 10.0 | 249.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 9.6 | 538.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 9.5 | 152.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 9.4 | 234.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 9.4 | 37.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 9.3 | 83.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 9.2 | 203.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 9.2 | 91.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 9.0 | 189.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 9.0 | 278.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 8.9 | 133.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 8.8 | 211.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 8.6 | 43.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 8.4 | 185.2 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
| 8.2 | 156.4 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 8.1 | 169.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 8.1 | 153.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 7.9 | 206.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 7.9 | 134.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 7.9 | 363.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 7.9 | 276.0 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 7.4 | 66.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 7.1 | 538.7 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 7.0 | 365.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 7.0 | 7.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 6.9 | 358.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 6.3 | 57.0 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 6.3 | 500.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 6.3 | 151.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 6.1 | 128.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 6.0 | 180.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 5.9 | 148.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 5.9 | 99.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 5.9 | 258.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 5.8 | 279.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 5.6 | 423.6 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
| 5.5 | 136.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 5.4 | 637.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 5.4 | 48.4 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 5.2 | 88.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 5.2 | 62.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 5.2 | 154.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 5.1 | 86.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 5.1 | 71.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 5.0 | 60.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 5.0 | 95.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 5.0 | 341.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 4.9 | 59.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 4.9 | 117.1 | REACTOME TRANSLATION | Genes involved in Translation |
| 4.7 | 142.0 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
| 4.7 | 84.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 4.7 | 79.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 4.6 | 473.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 4.6 | 110.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 4.6 | 36.9 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
| 4.6 | 252.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 4.5 | 58.9 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
| 4.4 | 505.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 4.4 | 104.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 4.0 | 606.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 3.9 | 93.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 3.8 | 98.6 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 3.8 | 49.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 3.8 | 7.5 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
| 3.8 | 154.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 3.7 | 51.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 3.7 | 47.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 3.5 | 102.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 3.5 | 14.0 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 3.5 | 69.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 3.5 | 58.9 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 3.5 | 62.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 3.4 | 17.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 3.4 | 78.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 3.4 | 37.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 3.3 | 36.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 3.3 | 26.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 3.1 | 58.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 3.1 | 97.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 3.0 | 94.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 2.9 | 34.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 2.9 | 65.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 2.8 | 79.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 2.8 | 36.5 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
| 2.8 | 5.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 2.8 | 22.4 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
| 2.8 | 50.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 2.8 | 93.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 2.7 | 89.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 2.6 | 54.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 2.6 | 5.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 2.5 | 47.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 2.4 | 4.8 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 2.4 | 98.7 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 2.3 | 65.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 2.3 | 36.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 2.2 | 35.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 2.2 | 25.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 2.1 | 31.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 2.0 | 40.0 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| 2.0 | 19.6 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 1.9 | 41.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 1.8 | 27.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 1.8 | 17.8 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 1.8 | 65.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 1.8 | 136.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 1.7 | 8.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 1.7 | 24.3 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
| 1.6 | 16.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 1.6 | 16.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 1.6 | 44.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 1.6 | 21.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 1.6 | 25.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 1.5 | 4.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 1.5 | 28.9 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 1.5 | 97.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 1.4 | 89.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 1.4 | 98.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 1.4 | 32.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 1.4 | 40.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 1.3 | 26.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 1.2 | 8.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 1.1 | 36.9 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 1.1 | 20.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 1.0 | 24.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 1.0 | 15.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 1.0 | 5.0 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 1.0 | 2.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 1.0 | 3.9 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 1.0 | 49.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.9 | 14.6 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.8 | 11.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.8 | 5.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.8 | 98.0 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
| 0.8 | 4.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.7 | 1.4 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.7 | 1.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
| 0.7 | 12.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.7 | 2.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.6 | 12.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.6 | 1.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.6 | 9.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.6 | 3.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.5 | 41.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.5 | 11.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.4 | 4.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.3 | 2.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.3 | 25.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.3 | 2.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.2 | 1.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 2.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.2 | 21.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.2 | 2.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.2 | 22.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.2 | 4.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.2 | 19.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.2 | 1.5 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.2 | 6.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 1.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.1 | 2.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 2.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.1 | 2.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.1 | 0.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.1 | 1.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.1 | 0.8 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |